Febrile IllnessNCT01288846
Medication List in and Out of Hospital
An observational study of Febrile Illness and Acute Cardiovascular Disease, run by University of Oslo at 1 site in Norway.
Trial summary
30 patients acute hospitalized to medical ward and their medication records are examined. It is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Febrile Illness, Acute Cardiovascular Disease, Acute Respiratory Disease
- How many people
- 30 participants
- Where
- 1 siteNorway
- Study dates
- Mar 2011to Dec 2011
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Acutely hospitalized patients into medical ward
Who may be able to join
- acute hospitalized to medical ward
- using three or more drugs, prescription only
Who cannot join
- not been able to give consent, if too severely ill or not mentally capable
Trial locations and contacts
1 site in 1 country.
Norway1 site
Sykehuset Innlandet HF Gjøvik
Gjøvik, 2819
Øystein Stubhaug, Clinic shief, +4761157002, oistein.stubhaug@sykehuset-innlandet.no
About this study
Official title: Communication About Medication Through the Medication List Coming Into the Hospital With the Patient, Being Changed in the Hospital and Then Returning With the Patient to the Community.
30 patients acute hospitalized to medical ward and their medication records are examined. It is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.
Read the detailed description
Furthermore is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient and how long it takes to find the right medicine list. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.
This shall be recorded in the review of 30 patient with a focus on their medication list and follow them from admission to a month after discharge.
Medicine List in discharge summaries will be compared with medication written in journal during hospital stay and changes described in the text summaries and medication lists should be checked against the same journal.
Medicine list in the municipality one month after discharge shall be compared with discharge summaries and it will be mapped on the GP register, modified and considered if they are valid.
Hypothesis:
Medicine list is missing at admission by > 50% of patients admitted acutely into hospital.
Medicine List at admission, when available, is often incomplete. When the medication list is not available at admission, its content is often incomplete even after the staff at reception have tried to gather information from different sources.
Changes of regular medication is not always present in the discharge summaries. The changes are not always justified in the discharge summaries. The GP often do not correct the medication list in the journal to the discharge summary.
The GP does not give the patient an updated printout of the list at the first medical consultation after admission.
- Keywords
- medication list, changes in medication, prescription medication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Acutly ill, Medical ward, consent | group of acutely ill patient who uses three or more drugs, must be able to give consent. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Changes in medication
It is studied when the patient is still in hospital an 1 month after he is at home.
Measured: after 2 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Feb 2011 (estimated)
- Study startMar 2011
- Primary completionMar 2011 (estimated)
- Study completionDec 2011 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Febrile IllnessStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Oslo
- Sponsor type
- University, hospital or other
- Investigators
- Mette Brekke, professor, Study director, University of Oslo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01288846
- Sponsor's protocol ID
- MBKF-03-UiO
- Status last verified
- Jan 2011
- First submitted
- 2 Feb 2011
- Last updated
- 4 Feb 2011
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 4 Feb 2011. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Communication About Medication Through the Medication List Coming Into the Hospital With the Patient, Being Changed in the Hospital and Then Returning With the Patient to the Community.
- ClinicalTrials.gov ID
- NCT01288846
- Acronym / sponsor ID
- MBKF-03-UiO
- Keywords
- medication list, changes in medication, prescription medication
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- University of OsloUniversity, hospital or other
- Study start
- Mar 2011
- Primary completion
- Mar 2011 (estimated)
- Study completion
- Dec 2011 (estimated)
- First posted
- 3 Feb 2011 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
30 patients acute hospitalized to medical ward and their medication records are examined. It is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.
Detailed description
Furthermore is to be recorded how the investigators find information about medicine use by the reception when they do not follow the patient and how long it takes to find the right medicine list. The record of the changes made during hospital stay is examined, whether they are justified in the discharge summaries and whether they are described in the medical list. After a month is to find out if the GP has recorded or possibly rejected changes to medication made in hospital.
This shall be recorded in the review of 30 patient with a focus on their medication list and follow them from admission to a month after discharge.
Medicine List in discharge summaries will be compared with medication written in journal during hospital stay and changes described in the text summaries and medication lists should be checked against the same journal.
Medicine list in the municipality one month after discharge shall be compared with discharge summaries and it will be mapped on the GP register, modified and considered if they are valid.
Hypothesis:
Medicine list is missing at admission by > 50% of patients admitted acutely into hospital.
Medicine List at admission, when available, is often incomplete. When the medication list is not available at admission, its content is often incomplete even after the staff at reception have tried to gather information from different sources.
Changes of regular medication is not always present in the discharge summaries. The changes are not always justified in the discharge summaries. The GP often do not correct the medication list in the journal to the discharge summary.
The GP does not give the patient an updated printout of the list at the first medical consultation after admission.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Acutly ill, Medical ward, consent | – | –group of acutely ill patient who uses three or more drugs, must be able to give consent. |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Acutely hospitalized patients into medical ward
Key inclusion criteria (2 listed)
- acute hospitalized to medical ward
- using three or more drugs, prescription only
Key exclusion criteria (1 listed)
- not been able to give consent, if too severely ill or not mentally capable
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Changes in medication
Time frame: after 2 months
It is studied when the patient is still in hospital an 1 month after he is at home.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Feb 2011.
Related trials for Febrile Illness
RecruitingObservational study
Knowledge, Attitudes, Perceptions and Behaviors of Healthcare Professionals and the General Population Regarding Vaccination During Febrile Illness
Febrile Illness
RecruitingObservational study
Triage Performance and Physiological Predictors of Serious Illness in Febrile Children in the Pediatric Emergency Department
Fever, Triage
Recruiting
A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
Infectious Disease, Febrile Illness
Recruiting
Working in the Heat at Simulated Altitude: Effects of Normobaric Hypoxia on Physiological Strain
Body Temperature Changes, Heat Stress
RecruitingPhase 2/3
A Study of CP-COV03 Compared With Placebo in Participants With Dengue (Part 1) and Dengue-like Illness (Part 2)
Dengue
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mette Brekke, professor study director
University of Oslo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Febrile Illness and Acute Cardiovascular Disease, run by University of Oslo at 1 site in Norway.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 4 Feb 2011. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Karin Frydenberg, GP (+4790863737, frydrein@online.no), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Changes in medication (time frame: after 2 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2011.